- Regulation of scr-family of protein tyrosine kinases
-
Seo JS
- KMID: 1686850
- J Korean Soc Endocrinol.
- 1993 Jun;8(2):119-124.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Autophosphorylation and tyrosine kinase activity of purified insulin receptors
-
Choi WH, Ahn YH, Kim TW, Kim M
- KMID: 1699993
- J Korean Diabetes Assoc.
- 1991 Dec;15(2):173-182.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Characterization of a Point Mutation in the First Intron of Bruton's Tyrosine Kinase ( Btk ) Gene
-
Jo EK, Song CH, Song YJ, Min DL, Kim HJ, Lim K, Shong MH, Lee JH, Kim JS, Park JK
- KMID: 1646429
- Korean J Immunol.
- 2000 Dec;22(4):197-205.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Detection of the amplified tyrosine kinase domain in the insulin receptor beta-subunit by the PCR method
-
Choi WH, Yoo GS, Koh KA, Chung HJ, Kim HY, Shin HH, Han IK, Moon IG
- KMID: 1697908
- Korean J Intern Med.
- 1991 Jun;40(6):759-765.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Variations of MER Receptor Tyrosine Kinase and the Development of Chronic Obstructive Pulmonary Disease
-
Oh DK, Lee SW
- KMID: 2402999
- J Korean Med Sci.
- 2018 Feb;33(7):e57.
- doi: 10.3346/jkms.2018.33.e57
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Gray Hair Associated with the Multitargeted Receptor Tyrosine Kinase Inhibitor Pazopanib
-
Yun HJ, Seo YJ, Lee HJ
- KMID: 2157470
- Ann Dermatol.
- 2015 Dec;27(6):791-792.
- doi: 10.5021/ad.2015.27.6.791
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Depigmentation in a Patient with Chronic Myeloid Leukemia during Chemotherapy with Dasatinib
-
Choi YW, Na N, Park J
- KMID: 2451599
- Korean J Dermatol.
- 2019 Jun;57(5):292-293.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Molecular Basis of Drug Resistance: Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Anaplastic Lymphoma Kinase Inhibitors
-
Yang SH
- KMID: 2320467
- Tuberc Respir Dis.
- 2013 Nov;75(5):188-198.
Over the past decade, several kinase inhibitors have been approved based on their clinical benefit in cancer patients. Unfortunately, in many cases, patients develop resistance to these agents via secondary... -
- CITED
-
- Close
- SHARE
-
- Close
- Regulation of Protein Kinase in KCl-induced Contraction of Cat Gastric Smooth Muscle
-
Kim MS, Jo YH, Yoon SH, Hahn SJ, Sim SS, Shim HS, Rhie DJ, Kim SR
- KMID: 2304693
- Korean J Gastroenterol.
- 1998 Sep;32(3):290-297.
BACKGROUND AND AIMS: Smooth muscle contraction and relaxation are suggested to be modulated by intracellular Ca2+, protein kinases and tyrosine kinases. To investigate whether protein kinases are invelved in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Primary Extragastrointestinal Stromal Tumor of Retroperitoneum: Poor Response to Tyrosine Kinase Inhibitor
-
Lee MY
- KMID: 2437774
- Soonchunhyang Med Sci.
- 2018 Jun;24(1):88-91.
- doi: 10.0000/sms.2018.24.1.88
Gastrointestinal stromal tumors (GIST) are the most common sarcomas arising in the gastrointestinal tract. Stromal tumors arising outside the gastrointestinal tract are known as extragastrointestinal stromal tumors (EGIST). EGISTs may... -
- CITED
-
- Close
- SHARE
-
- Close
- Activation of Protein Tyrosine Kinase Pathway after Cat BRVO
-
Kim HC, Juan ED
- KMID: 2022680
- J Korean Ophthalmol Soc.
- 1998 Feb;39(2):292-301.
To examine the effect of retinal branch vein occlusion (BRVO) on protein tyrosine phosphorylation, production of angiogenic growth factors, and activation of signal proteins in the tyrosine kinase pathways in... -
- CITED
-
- Close
- SHARE
-
- Close
- EGFR Tyrosine Kinase Inhibitors for NSCLC
-
Kim YC
- KMID: 1881512
- J Lung Cancer.
- 2005 Dec;4(2):71-73.
The EGFR Tyrosine kinase inhibitors (TKIs) show significant clinical benefit in selected population with no smoking history, adenocarcinoma or mutations in EGFR gene. Mutations of K-ras gene are associated with... -
- CITED
-
- Close
- SHARE
-
- Close
- Role of Tyrosine Kinases in 5-HT-Induced Vascular Contraction in Two-Kidney, One Clip Hypertensive Rats
-
Yeum CH, Kim JS, Jun JY, Kim JH, Liee JH, Yoon PJ
- KMID: 2254581
- Korean J Nephrol.
- 2000 Jan;19(1):40-48.
Tyrosine kinases have been implicated in vascular smooth muscle cell proliferation and contraction. The involvement of tyrosine kinases in 5-hydroxytryptamine (5-HT)-induced contractile response of the isolated aorta was examined in... -
- CITED
-
- Close
- SHARE
-
- Close
- Skin-Related Toxicity of Tyrosine Kinase Inhibitor in Thyroid Cancer
-
Lim DJ
- KMID: 2448976
- Int J Thyroidol.
- 2018 Nov;11(2):82-87.
- doi: 10.11106/ijt.2018.11.2.82
Skin-related toxicity is one of the most important adverse events from multi-target tyrosine kinase inhibitor (MTKI) to treat radioiodine refractory thyroid cancer. As hand foot skin reaction can limit quality... -
- CITED
-
- Close
- SHARE
-
- Close
- Muscle-specific receptor tyrosine kinase (MuSK) myasthenia gravis associated with castleman disease
-
Oh J, Yang WI, Cho JH, Sunwoo IN
- KMID: 2368001
- Ann Clin Neurophysiol.
- 2017 Jan;19(1):74-76.
- doi: 10.14253/acn.2017.19.1.74
Muscle specific tyrosine kinase (MuSK) myasthenia gravis (MG) is a rare subtype of MG, which is immunologically distinct and differential therapeutic response. Though MG is often associated with other autoimmune... -
- CITED
-
- Close
- SHARE
-
- Close
- Phosphorylation of chicken protein tyrosine phosphatase 1 by casein kinase II in vitro
-
Jung EJ, Kang KR, Kang YS
- KMID: 1532667
- Exp Mol Med.
- 1997 Dec;29(4):229-233.
The phosphorylation and dephosphorylation of proteins on tyrosyl residues are key regulatory mechanisms of cell growth and signal transduction and are controlled by opposing activities of protein tyrosine kinases and... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Bleeding Induced by Tyrosine Kinase Inhibitor in Radioiodine Refractory Thyroid Cancer
-
Shin DY
- KMID: 2448973
- Int J Thyroidol.
- 2018 Nov;11(2):71-74.
- doi: 10.11106/ijt.2018.11.2.71
Adverse events such as hemoptysis and gastrointestinal hemorrhage during tyrosine kinase inhibitor treatment are relatively rare, but the severity of the bleeding can be higher than other common adverse events.... -
- CITED
-
- Close
- SHARE
-
- Close
- Activation of Protein Tyrosine Kinase Pathways After Rat Retinal Vein Occlusion
-
Kim HC
- KMID: 2336790
- J Korean Ophthalmol Soc.
- 1999 Feb;40(2):470-480.
To determine whether an experimental retinal vein occlusion activates protein tyrosine kinase pathwas andincreases angiogenic growth factors in the rat retina. Retinal vein occlusion (RVO) was induced in the rat... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Severe Fatigue Induced by Tyrosine Kinase Inhibitor in Radioiodine Refractory Thyroid Cancer
-
Ahn BC
- KMID: 2448974
- Int J Thyroidol.
- 2018 Nov;11(2):75-77.
- doi: 10.11106/ijt.2018.11.2.75
Tyrosine kinase inhibitor is known to prolong progression free survival in radioiodine refractory thyroid cancer patients. Fatigue/asthenia/malaise is one of most common adverse events by the tyrosine kinase inhibitor treatment,... -
- CITED
-
- Close
- SHARE
-
- Close
- Role of protein kinases on NF- kappaB activation and cell death in bovine cerebral endothelial cells
-
Ahn YS, Kim CH, Kim JH
- KMID: 1917065
- Korean J Physiol Pharmacol.
- 1999 Feb;3(1):11-18.
Nuclear factor kappaB (NF- kappaB) activation is modulated by various protein kinases. Activation of NF- kappaB is known to be important in the regulation of cell viability. The present study investigated the effect... -
- CITED
-
- Close
- SHARE
-
- Close
